High refractive index haloalkyl-functional shell-core polymers and their use in light scattering immunoassays

• US 4,703,018 A
• Filed: 02/20/1985
• Issued: 10/27/1987
• Est. Priority Date: 02/20/1985
• Status: Expired due to Term

• Current Assignee: Dade Behring, Inc. (Siemens AG)
• Original Assignee: E. I. du Pont de Nemours and Company (Corteva, Inc.)
• Inventors: Craig, Alan R., Gorman, Eileen G.
• Primary Examiner(s): Nucker, Christine M.
• Application Number:
  US06/703,424
• Time in Patent Office: 979 Days
• Field of Search: 436/518, 436/528, 436/531, 436/532, 436/533, 436/534, 436/823, 436/805
• US Class Current: 436/518
• CPC Class Codes: C08F 2/22 Emulsion polymerisation
• CPC Class Codes: C08F 291/00 Macromolecular compounds obtained by polymerising monomers on to macromolecular compounds according to more than one of the groups C08F251/00 - C08F289/00
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form
• CPC Class Codes: Y10S 436/805 Optical property
• CPC Class Codes: Y10S 436/823 Immunogenic carrier or carrier per se

Abstract

Novel particle reagent for light scattering immunoassays are provided. The particle reagents are high refractive index shell-core polymers, having at least a partial surface coverage by a monomolecular layer of anionic surfactant, covalently bonded to compounds of biological interest. The novel particle reagents are particularly suited to protein immobilization by covalent bonding to the shell and are especially useful for light scattering immunoassays.

Claims

1. A particle reagent having high refractive index consisting essentially of:

(A) a polymer particle having an inner core and an outer shell wherein the inner core is a polymer having a refractive index of not less than 1.54 as measured at the wavelength of the sodium D line and wherein the outer shell is a polymer of

(1) five to about seventy parts by weight of the outer shell of an ethylenically unsaturated monomer having a haloalkyl functional group capable of reacting with a compound of biological interest, its antigen or its antibody, selected from the group consisting of ##STR2## wherein X is Cl or Br and R is H, CH₃, or C₂ H₅, (2) 95 to about 30 parts by weight of other ethylenically unsaturated monomers selected in amounts not to result in the formation of water soluble polymer particles, and

(3) not more than 10 parts by weight of the outer shell of the residual monomers of the inner core;

said outer shell being formed by polymerization in the presence of said inner core; and

wherein said polymer particle has an approximate diameter range of 0.01-1.0 μ

m, a 5-100% surface coverage by a monomolecular layer of anionic surfactant, and is covalently attached to

(B) a compound of biological interest, its antigen or its antibody.

2. The particle reagent of claim 1 wherein said outer shell contains at least ten parts by weight of the outer shell of the haloalkyl monomer.

3. The particle reagent of claim 1 wherein said outer shell is not more than ten parts by weight of the polymer particle.

4. The particle reagent of claim 1 wherein the haloalkyl monomer is chloromethylstyrene (X=Cl and R=H).

5. The particle reagent of claim 1 wherein the anionic surfactant covers 40-100% of the polymer particle surface.

6. A method for measuring compounds of biological interest comprising the steps of

(A) incubating

(a) a first particle reagent having a high refractive index consisting essentially of:

(i) a polymer particle having an inner core and an outer shell wherein the inner core is a polymer having a refractive index of not less than 1.54 as measured at the wavelength of the sodium D line and wherein the outer shell is a polymer of

(1) five to about seventy parts by weight of the outer shell of an ethylenically unsaturated monomer having a haloalkyl functional group capable of reacting with a compound of biological interest, its antigen or its antibody, selected from the group consisting of ##STR3## wherein X is Cl or Br and R is H, CH₃, or C₂ H₅, (2) 95 to about 30 parts by weight of other ethylenically unsaturated monomers selected in amounts not to result in the formation of water soluble polymer particles, and

(3) not more than 10 parts by weight of the outer shell of the residual monomers of the inner core;

said outer shell being formed by polymerization in the presence of said inner core; and

wherein said polymer particle has an approximate diameter range of 0.01-1.0 μ

m, a 5-100% surface coverage by a monomolecular layer of anionic surfactant, and is covalently attached to

(ii) a compound of biological interest or its antibody;

(b) a liquid suspected of containing the compound of biological interest or its analog; and

(c) an agglutinating agent; and

(B) photometrically measuring increased particle size resulting from agglutination.

7. The method of claim 6 wherein the agglutinating agent is selected from the group consisting of

(A) a second particle reagent having high refractive index consisting essentially of:

(a) a polymer particle having an inner core and an outer shell wherein the inner core is a polymer having a refractive index of not less than 1.54 as measured at the wavelength of the sodium D line and wherein the outer shell is a polymer of

(1) five to about seventy parts by weight of the outer shell of an ethylenically unsaturated monomer having a haloalkyl functional group capable of reacting with a compound of biological interest, its antigen or its antibody, selected from the group consisting of ##STR4## wherein X is Cl or Br and R is H, CH₃, or C₂ H₅, (2) 95 to about 30 parts by weight of other ethylenically unsaturated monomers selected in amounts not to result in the formation of water soluble polymer particles, and

(3) not more than 10 parts by weight of the outer shell of the residual monomers of the inner core;

said outer shell being formed by polymerization in the presence of said inner core; and

wherein said polymer particle has an approximate diameter range of 0.01-1.0 μ

m, a 5-100% surface coverage by a monomolecular layer of anionic surfactant, and is covalently attached to

(b) a compound of biological interest, its antigen or its antibody selected to be immunochemically complementary to the compound of biological interest or its antibody; and

(B) an antibody to the compound of biological interest.

8. The method of claim 6 wherein during the incubation step (A) there is also present an agglutinating accelerator.

9. A method for measuring antibodies comprising the steps of

(A) incubating

(a) a particle reagent having a high refractive index consisting essentially of:

(i) a polymer particle having an inner core and an outer shell wherein the inner core is a polymer having a refractive index of not less than 1.54 as measured at the wavelength of the sodium D line and wherein the outer shell is a polymer of

(1) five to about seventy parts by weight of the outer shell of an ethylenically unsaturated monomer having a haloalkyl functional group capable of reacting with a compound of biological interest, its antigen or its antibody, selected from the group consisting of ##STR5## wherein X is Cl or Br and R is H, CH₃, or C₂ H₅, (2) 95 to about 30 parts by weight of other ethylenically unsaturated monomers selected in amounts not to result in the formation of water soluble polymer particles, and

(3) not more than 10 parts by weight of the outer shell of the residual monomers of the inner core;

said outer shell being formed by polymerization in the presence of said inner core; and

wherein said polymer particle has an approximate diameter range of 0.01-1.0 μ

m, a 5-100% surface coverage by a monomolecular layer of anionic surfactant, and is covalently attached to

(ii) an antibody to the antibody or an antigen of the antibody;

(b) a liquid suspected of containing the antibody; and

(c) an agglutinating agent; and

(B) photometrically measuring increased particle size resulting from agglutination.

10. A method for measuring compounds of biological interest comprising the steps of

(A) incubating

(a) a particle reagent having a high refractive index consisting essentially of:

(i) a polymer particle having an inner core and an outer shell wherein the inner core is a polymer having a refractive index of not less than 1.54 as measured at the wavelength of the sodium D line and wherein the outer shell is a polymer of

(1) five to about seventy parts by weight of the outer shell of an ethylenically unsaturated monomer having a haloalkyl functional group capable of reacting with a compound of biological interest, its antigen or its antibody, selected from the group consisting of ##STR6## wherein X is Cl or Br and R is H, CH₃, or C₂ H₅, (2) 95 to about 30 parts by weight of other ethylenically unsaturated monomers selected in amounts not to result in the formation of water soluble polymer particles, and

(3) not more than 10 parts by weight of the outer shell of the residual monomers of the inner core;

said outer shell being formed by polymerization in the presence of said inner core; and

wherein said polymer particle has an approximate diameter range of 0.01-1.0 μ

m, a 5-100% surface coverage by a monomolecular layer of anionic surfactant, and is covalently attached to

(ii) the antibody to the compound of biological interest;

(b) a liquid suspected of containing the compound of biological interest or its analog; and

(B) photometrically measuring increased particle size resulting from agglutination.